Hepatitis C virus infection and the rising incidence of hepatocellular carcinoma

Mayo Clinic Proceedings

Volumn 87, Issue 1, 2012, Pages 7-8

  Harnois, Denise M ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN;

ALCOHOL LIVER DISEASE; CANCER INCIDENCE; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; EDITORIAL; ETHNIC DIFFERENCE; ETHNIC GROUP; GEOGRAPHIC DISTRIBUTION; HEPATITIS B; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK POPULATION; HISTOLOGY; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; MEDICAL RECORD REVIEW; POPULATION RESEARCH; PRACTICE GUIDELINE; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SCREENING TEST; SURVIVAL RATE; TREND STUDY; TUMOR DIAGNOSIS; VIRUS HEPATITIS; VIRUS TRANSMISSION;

EID: 84855662609     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mayocp.2011.11.004     Document Type: Editorial

References (18)

1. El-Serag HB. Hepatocellular carcinoma. N Engl J Med. 2011;365(12):1118- 1127.
2. Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat database: incidence - SEER 9 Regs research data, Nov 2009 Sub (1973-2007). Bethesda, MD: National Cancer Institute; 2010.
3. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide. IARC CancerBase No. 10 Lyon, France: International Agency for Research on Cancer. http://globocan.iarc.fr. Accessed December 7, 2011.
4. The World Health Organization. GLOBOCAN 2002. http://www.emro.who.int/ ncd/cancer-globocan.htm. Accessed December 7, 2011.
5. Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol. 2009;27(9):1485-1491.
6. Yang JD, Kim B, Sanderson SO, et al. Hepatocellular carcinoma in Olmsted County, Minnesota, 1976-2008. Mayo Clin Proc. 2012;87(1):9-16.
7. Shire AM, Sandhu DS, Kaiya JK, et al. Viral hepatitis among Somali immigrants in Minnesota: association of hepatitis C with hepatocellular carcinoma. Mayo Clin Proc. 2012;87(1):17-24.
8. Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53(3):1020-1022.
9. Sherman M, Burak K, Maroun J, et al. Multidisciplinary Canadian consensus recommendations for the management and treatment of hepatocellular carcinoma. Curr Oncol. 2011;18(5):228-240.
10. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology. 2005;42(5):1208-1236. (Pubitemid 43112690)
11. Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology. 2004;127(5, suppl 1):S35-S50. (Pubitemid 39423368)
12. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348(17):1625-1638. (Pubitemid 36459468)
13. El-Serag HB, Tran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology. 2004;126(2):460-468. (Pubitemid 38182303)
14. Zhang BH, Yang BH, Tang ZY. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol. 2004;130(7):417-422.
15. Harnois DM, Steers J, Andrews JC, et al. Preoperative hepatic artery chemoembolization followed by orthotopic liver transplantation for hepatocellular carcinoma. Liver Transpl Surg. 1999;5(3):192-199. (Pubitemid 29217989)
16. Arii S, Yamaoka Y, Futagawa S, et al The Liver Cancer Study Group of Japan. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology. 2000;32(6):1224-1229.
17. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362(9399):1907-1917. (Pubitemid 37518510)
18. Davila JA, Henderson L, Kramer JR, et al. Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States. Ann Intern Med. 2011;154(2):85-93.